MicroRNAs (miRNAs) are a class of small (~21-25 nucleotides) singlestranded RNAs that can inhibit the expression of specific messenger RNAs by binding to complementary target sequences within the mRNAs. Viruses were first reported to express miRNAs in 2004 (ref. 1), when Thomas Tuschl and colleagues described five mi RNAs that were produced in human B cells after infection with the γ-herpesvirus EpsteinBarr virus (EBV). Subsequently, miRNAs have been found to be expressed by all of the herpesviruses examined. EBV is now known to encode at least 23 miRNAs 2, 3 , and the distantly related human γ-herpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV) encodes 12 (refs 3-5). Similarly, the β-herpesvirus human cytomegalovirus (HCMV) encodes 11 miRNAs 5, 6 , and the human α-herpesvirus herpes simplex virus 1 (HSV-1) encodes at least 6 miRNAs 7, 8 . (These numbers refer to the known premiRNA precursors encoded by each virus. A pre-miRNA can give rise to a single mature miRNA or to two miRNAs, one of which will be more abundant.) Several miRNAs have also been identified in herpesviruses that infect other species, including the simian γ-herpesviruses rhesus rhadinovirus 9 and rhesus lympho cryptovirus 2 , murine γ-herpesvirus 68 (MHV68) 5 , murine cytomegalovirus 10, 11 , and the avian α-herpesviruses Marek's disease virus types 1 and 2 (refs 12, 13).
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Unlike herpesviruses (which are a family of DNA viruses), other, unrelated, DNA viruses seem to encode either one or two miRNAs (for example, primate polyoma viruses and human adenoviruses) or none at all 5, [14] [15] [16] [17] . Viruses that have an RNA genome, including retroviruses and flaviviruses, have been reported to lack miRNAs 5, 17 , although this result remains somewhat controversial for human immunodeficiency virus 1 (HIV-1) 18 . The absence of viral miRNAs in the RNA viruses examined so far might be partly explained by the fact that if the viral genome contained an appropriate precursor, this might be excised by the miRNA-processing enzyme of the host cell (that is, by Drosha) 19 , resulting in degradation of the viral genome. Moreover, most RNA viruses -as well as DNA viruses belonging to the poxvirus family -replicate in the cytoplasm, away from the nucleus, where the Drosha-containing microprocessor complex is located. Therefore, even if the genomes of these cytoplasmic viruses encode a miRNA, it is not apparent how they could be processed to yield a mature miRNA.
It is less clear why miRNAs seem to be rare in nuclear-replicating DNA viruses that are not members of the herpesvirus family. It seems possible that the presence of miRNAs in herpesviruses is associated with the characteristic ability of herpesviruses to establish long-term latent infections. Avoiding the host immune response is particularly important during latent infection, and viral miRNAs not only have the advantage of not being recognized by the host immune system but also might be an ideal tool for attenuating immune responses by downregulating the expression of key cellular genes. Moreover, miRNAs might provide a way to regulate the entry of herpesviruses to the latent stage of the life cycle and/or their exit from this stage 20 . Other DNA virus families usually establish productive infections that often result in the infected cell's dying rapidly as a result of pathogenic factors produced by the virus or cytotoxic responses induced in the host. On the one hand, given that miRNAs operate at the level of the mRNA, they might not be as useful during a productive (lytic) replication cycle, because the proteins encoded by the targeted mRNAs might have a half-life that approaches, or even exceeds, the duration of the viral life cycle. On the other hand, viral miRNAs could be effective inhibitors of cellular mRNAs that are produced de novo during infection and that might encode proteins with antiviral activities. It will be interesting to see whether additional viral miRNAs, encoded by DNA viruses other than those of the herpesvirus family, will be uncovered in the future. In this Review, I briefly discuss what is known about the biogenesis and function of the known viral miRNAs, focusing on the limited number of viral and cellular mRNA targets that have been identified for these viral miRNAs so far.
Viral miRNA generation
The genomic regions encoding cellular miRNAs are generally transcribed by RNA polymerase II. The initial product is a capped, polyadenylated transcript that includes one or more stem-loop structures, each of which contains a mature miRNA sequence as part of one arm (Fig. 1) . This precursor is known as a primary miRNA (pri-miRNA) 19 (see page 396 for further details about miRNA biogenesis). The nuclease Drosha cleaves the pri-miRNA stem, excising hairpin intermediates of ~65-70 nucleotides known as precursor miRNAs (pre-miRNAs). These are exported to the cytoplasm and processed by another nuclease, Dicer, generating mature miRNAs of ~22 nucleotides. The miRNAs are loaded into a protein complex known as the RNA-induced silencing complex (RISC), which they then guide to the target mRNA to exert their effector function. Binding of the RISC to an mRNA bearing extensive sequence complementarity to the miRNA generally results in mRNA cleavage and degradation, whereas binding to mRNAs bearing partial complementarity results mainly in translational arrest. At present, there is no evidence that any vertebrate virus encodes novel miRNA-processing factors or RISC components. So it seems that, in general, viral miRNAs are transcribed and processed in the same way as cellular miRNAs and, moreover, that RISCs programmed by viral miRNAs are functionally equivalent to those programmed by cellular miRNAs (Fig. 1) . One exception is miRNAs encoded by MHV68 and by human adenoviruses, because the regions of the viral genome encoding these miRNAs are initially transcribed by RNA polymerase III (refs 5, 16) . Although the processing steps involved in the biogenesis of MHV68 miRNAs remain to be fully elucidated, mature MHV68 and human adenovirus miRNAs are probably excised by Dicer and loaded into the RISC normally.
A key characteristic of DNA viruses is that gene expression during productive replication is temporally regulated: viral proteins can be subdivided into immediate early, early, and late species. Immediate early gene products are usually regulatory proteins. Early proteins are more diverse and are often involved in viral genome replication or in host immune response regulation. Late proteins are usually structural. The γ-herpesviruses, in particular, also produce viral proteins during latency, and these proteins have roles in episome maintenance, cell growth regulation and immune evasion. It is important therefore to consider whether the expression of viral miRNAs is also temporally regulated. For most herpesviruses, this is unclear at present, because the known viral miRNAs have been cloned either exclusively from latently infected cells or from cells at a relatively late stage in productive replication. However, there is evidence indicating that some viral miRNAs are active during latency, whereas others are more important during productive replication. For example, in the case of KSHV, all 12 viral mi RNAs are derived from a cluster that is transcribed as a single primi RNA during latent infection. During the tran sition to productive replication, a viral lytic promoter is activated, and this promoter lies 3ʹ to the genomic sequences encoding ten of the KSHV miRNAs but 5ʹ to the genomic sequences encoding two of them. Consequently, the expression of ten of the KSHV miRNAs is largely unaffected when productive replication is activated, whereas the expression of two of the miRNAs is substantially induced 5, 21 . In the case of HCMV, the 11 known viral miRNAs were all identified in productively infected cells 5, 6 , and most of these viral miRNAs seem to be produced with 'early' kinetics (that is, gene expression depends on viral immediate early transcription factors). It remains unclear which HCMV miRNAs are produced during latency. By contrast, in cells infected with HSV-1, four viral miRNAs seem to be expressed mainly during latency, one exclusively during productive replication and one during both stages 7, 8 . Finally, in cells infected with simian virus 40 (SV40), which is a polyoma virus, viral miRNAs are expressed with late kinetics 14 . A full appreciation of the functions of viral miRNAs will certainly require a more detailed understanding of how their expression is regulated during the viral life cycle. Although many viral miRNAs have now been identified, knowledge about their functions remains scarce. There are no published reports examining the in vivo phenotypes of viral mutants specifically lacking individual viral miRNAs, and only a small number of mRNA targets have been described (Tables 1 and 2 ). It can be envisaged that viral miRNAs evolved to downregulate cellular mRNAs and/or viral mRNAs (Fig. 1) . Cellular mRNA targets might include transcripts encoding proteins involved in host innate or adaptive immune responses or, more generally, involved in cell-cycle regulation or signal transduction. Viral mRNA targets might include transcripts involved in regulating the transition from latency to productive replication (or vice versa) or products of immediate early genes that need to be eliminated at later stages in the viral life cycle as a result of toxicity or because they are targets for host cytotoxic T cells 14, 20 . Although the current understanding is limited, the known targets of viral miRNAs have been found to belong to almost all of these categories.
Viral mRNA targets of viral miRNAs
The first paper to describe viral miRNAs also provided the first indication of a viral mRNA target for a viral miRNA. Specifically, one of the five EBV miRNAs described by Tuschl and colleagues 1 , miR-BART2, was found to lie antisense to the mRNA encoding the EBV DNA polymerase, also called BALF5, and was proposed to inhibit the production of DNA polymerase by inducing cleavage of this mRNA. Although there is evidence supporting partial inhibition of EBV DNA polymerase expression by miR-BART2 (ref. 22) , the functional significance of this inhibition is unknown. However, inhibiting EBV DNA polymerase expression might promote entry of the virus to latency by reducing viral genome amplification early after infection. Recently, it was reported 23 that a miRNA encoded by the insect DNA virus Heliothis virescens ascovirus (HvAV) also downregulates expression of the viral DNA polymerase. Unlike miR-BART2, the HvAV miRNA does not lie antisense to the viral DNA polymerase mRNA and has only moderate homology to the proposed mRNA target, but a reduction in the DNA polymerase mRNA level was nevertheless observed. The fact that two miRNAs, expressed by two unrelated viral species, both reduce the level of mRNAs encoding the cognate viral DNA polymerase might indicate convergent evolution.
Another example of a viral miRNA that is transcribed antisense to a viral mRNA, and induces degradation of that mRNA, occurs in the polyoma virus SV40. SV40 encodes a single pre-miRNA stem-loop structure that is expressed exclusively as a late gene product 14 . The viral miRNAs derived from this stem-loop structure lie antisense to the early viral mRNAs that encode the SV40 T antigens, which are viral transcription factors that induce the expression of late viral genes. These SV40 miRNAs, which show perfect complementarity to the T antigen mRNAs, induce the cleavage and degradation of the mRNAs and reduce T-antigen expression late in the SV40 life cycle. Epitopes derived from SV40 T antigens are recognized by cytotoxic T cells, and the effect of these viral miRNAs is therefore to partly protect SV40-infected cells from being killed by T cells 14 . 8, 24) . During latency, HSV-1 generates a set of five miRNAs: miR-H2-3p (3p denoting derivation from the 3ʹ side of the pre-miRNA stem), miR-H3, miR-H4, miR-H5 and miR-H6. One of these miRNAs, miR-H2-3p, lies antisense to the mRNA encoding the viral immediate early protein ICP0 and has been shown to downregulate ICP0 production 8 . Surprisingly, miR-H2-3p does not, however, induce ICP0 mRNA degradation, despite being fully complementary. Although the molecular basis for this phenom enon is unclear, other research groups have also reported examples of miRNAs or short interfering RNAs (a related class of small RNA) that reduce the expression of mRNAs bearing perfectly complementary targets mainly by inhibiting their translation 25, 26 . In addition to miR-H2-3p lying antisense to ICP0 transcripts, HSV-1 miR-H3 and miR-H4 lie antisense to the mRNAs encoding the pathogenicity factor ICP34.5 and, on the basis of genetic data, were proposed to inhibit ICP34.5 expression in latently infected neurons 8 . This hypothesis has now been validated for the related virus HSV-2, which encodes a miRNA similar to miR-H3 (called miR-I) 24 . When overexpressed in HSV-2-infected cells in culture, miR-I reduces the amount of ICP34.5 mRNA expressed and the amount of protein produced. A final example of an HSV-1 miRNA that targets a viral mRNA is provided by miR-H6, which was shown to downregulate production of the HSV-1 protein ICP4 (ref. 8 ). This miRNA does not lie antisense to the ICP4 gene in the HSV-1 genome, but it does show extensive complementarity to ICP4 mRNA, including the entire miRNA sequence extending from position 2 to position 8 (the miRNA 'seed' region). Full mRNA complementarity to the miRNA seed region is generally, but not always, required for inhibition of translation 19 . Overall, it seems that four of the six known HSV-1 miRNAs function to downregulate viral mRNAs in latently infected cells. The combined action of miR-H2-3p and miR-H6, which downregulate the production of the HSV-1 immediate early proteins ICP0 and ICP4, respectively, might increase the likelihood of HSV-1 entering latency and/or inhibit the tran sition from latency to productive replication 8 . The inhibition of ICP34.5 expression by miR-H3 and, potentially, miR-H4 is more difficult to explain, because ICP34.5 is a pathogenicity factor that blocks activation of the host antiviral factor PKR (double-stranded-RNA-activated protein kinase) and inhibits autophagy (an innate immune response in which cells are induced to degrade the bulk of their contents, including any newly formed virion particles) 27, 28 . Inhibiting ICP34.5 expression might shield latently infected neurons from the severe cytopathic effects induced by a full-blown HSV-1 productive replication cycle, and this idea is supported by the finding that HSV-1 mutants lacking the ICP34.5 gene are much less neurotoxic 28 . Another example of a viral miRNA that downregulates a crucial viral immediate early protein is the HCMV miRNA known as miR-UL112-1, which downregulates production of the viral protein IE1 (also known as IE72 and UL123) by targeting two partly complementary sites located in the 3ʹ untranslated region (UTR) of IE1 mRNAs 20, 29 . This observation prompted the proposal that herpesviruses in general might use miRNAs to regulate the expression of viral proteins that can trigger the transition from latency to productive replication 6 . This hypothesis is far from proven, but two observations are consistent with the idea. First, miRNAs produced in the latent stage of HSV-1 infection downregulate production Second, recent data show that viral miRNAs generated during KSHV latency downregulate the production of the KSHV immediate early proteins Rta and Mta, which are known to have a key role in the activation of productive KSHV replication (P. Konstantinova and B.R.C., unpublished observations).
A final example of a viral gene product that is downregulated by viral miRNAs is the EBV protein LMP-1, which has been reported to be suppressed by three EBV miRNAs, miR-BART1-5p, miR-BART16 and miR-BART17-5p 30 . LMP-1 is a cytoplasmic signalling molecule that is produced during EBV latency and can induce cell growth and transformation. However, overexpression of LMP-1 can result in growth inhibition and increased apoptosis 30 . So the role of these miRNAs might be to ensure an optimal level of LMP-1 expression during EBV latency.
Cellular mRNA targets of viral miRNAs
In principle, viral mRNA targets for viral miRNAs should be easier to identify than cellular mRNA targets. If a viral miRNA is antisense to a viral mRNA, then this suggests an obvious potential target, although not all viral mRNAs lying antisense to a viral miRNA are down regulated by that miRNA 31 . Even if the viral miRNA interacts with a partly com plementary viral mRNA, this should be an easier target to identify than a cellular mRNA, given that viral genomes are much smaller than host cell genomes. It could be envisaged that viral miRNAs evolved to efficiently degrade host cell mRNAs that encode particularly 'troublesome' host defence factors; however, no fully complementary cellular mRNA targets for viral miRNAs have been identified so far. Instead, viral miRNAs seem to inhibit the translation of cellular mRNAs bearing partly complementary sites: that is, viral miRNAs seem to function just like cellular miRNAs 19 (Table 2 ). An extreme example of this is the KSHV miRNA miR-K12-11, which has a seed region identical to the human cellular miRNA miR-155 and seems to downregulate an identical, or nearly identical, set of target mRNAs 32, 33 . The most fully characterized of these is BACH1 (BTB and CNC homology 1) mRNA, which contains several targets for both miR-K12-11 and miR-155 in its 3ʹ UTR. BACH1 is a transcriptional suppressor, and the significance of this downregulation for KSHV replication remains unclear. Even though several human genes downregulated by both miR-K12-11 and miR-155 have been identified 32, 33 , it is unclear why miR-K12-11 evolved to phenocopy miR-155. Overexpression of miR-155 is, however, associated with B-cell transformation, so miR-K12-11 might contribute to the transformation of B cells by KSHV 33 . Interestingly, the avian α-herpesvirus Marek's disease virus type 1 encodes a miRNA that also functions as an orthologue of miR-155 (ref. 34) , and EBV (although it does not itself encode a miR-155 equivalent) induces endogenous miR-155 production in infected B cells 35 . It therefore seems that downregulation of specific cellular genes by either miR-155 itself, or by viral orthologues of miR-155, might facilitate the replication of a range of different herpesviruses.
Another cellular gene that is downregulated by KSHV miRNAs is thrombospondin 1 (THBS1). THBS1 encodes a protein that is involved in facilitating cell-to-cell adhesion and has been reported to have antiproliferative and anti-angiogenic activities 36 . THBS1 expression is downregulated in Kaposi's sarcoma tumours, in keeping with the fact that tumour survival, particularly in highly vascularized Kaposi's sarcoma tumours, requires angiogenesis. Rolf Renne and colleagues 36 observed that THBS1 mRNA was downregulated in cells engineered to produce KSHV mi RNAs and also showed that translation of THBS1 mRNA is inhibited by several KSHV miRNAs, in particular by miR-K12-6-3p, which shows miRNA seed-region complementarity to two sites in the THBS1 mRNA 3ʹ UTR. It therefore seems possible that downregulation of THBS1 by KSHV miRNAs contributes to the development of Kaposi's sarcoma in vivo.
An obvious prediction is that viral miRNAs might downregulate cellular mRNAs encoding antiviral factors, and three such cellular targets have been uncovered. First, the HCMV miRNA miR-UL112-1 has been reported to target mRNAs encoding MICB (major histocompatibility complex class I polypeptide-related sequence B). MICB is a ligand for a cell-surface receptor of natural killer (NK) cells, which are innate immune cells that provide one of the early lines of defence against viral infection. The MICB-receptor interaction is a key regulator of NK-cell activity and hence of NK-cell killing of virus-infected cells 37 . The proposed target for miR-UL112-1 in the 3ʹ UTR of MICB mRNA is unusual in that it does not have complete complementarity to the seed region of miR-UL112-1, and in this case extensive complementarity to the central and 3ʹ regions of the miRNA might compensate 37 . Despite this lack of complete seed-region complementarity, cells producing miR-UL112-1 were found to display less cell-surface MICB and to be resistant to NKcell killing in vitro. Conversely, cells infected with a mutant form of HCMV lacking miR-UL112-1 had more cell-surface MICB and were killed more effectively by NK cells than were cells infected with wildtype HCMV. Interestingly, the function of MICB is also inhibited by the HCMV protein UL16, suggesting that UL16 and miR-UL112-1 might be functioning synergistically to protect infected cells against the NKcell arm of the human immune system 37 . Recently, it was reported that cellular miRNAs, including miR-93, also target the 3ʹ UTR of the MICB mRNA at sites that partly overlap with, but are distinct from, the site targeted by miR-UL112-1 (ref. 38) . Although these cellular miRNAs are not similar in sequence to the viral miRNA, it seems that miR-UL112-1 is mimicking the function of a subset of cellular mi RNAs and thereby exerting a similar protective effect against NK-cell killing. As discussed earlier, miR-UL112-1 has also been reported to downregulate production of the viral immediate early protein IE1 in HCMV-infected cells (Table 1) , thus providing the first example of a viral miRNA that targets both viral mRNAs and cellular mRNAs.
A second example of a viral miRNA that downregulates an antiviral factor is EBV miR-BART5, which inhibits production of the pro-apoptotic protein PUMA (p53-upregulated modulator of apoptosis) 39 . Depletion of miR-BART5 from EBV-infected nasopharyngeal carcinoma cells was found to trigger higher levels of PUMA-mediated apoptosis, suggesting that miR-BART5 might shield EBV-infected epithelial cells, as well as EBV-transformed cells, from elimination by apoptosis.
The third antiviral gene product known to be downregulated by a viral miRNA is CXC-chemokine ligand 11 (CXCL11), an interferoninducible T-cell chemoattractant. CXCL11 mRNA is downregulated by EBV miR-BHRF1-3, which is present in large amounts in many EBVinduced B-cell tumours 40 . CXCL11 has also been shown to have antitumour activity in animal studies, so this finding raises the possibility that, by downregulating CXCL11 production, miR-BHRF1-3 might shield EBV-infected B cells from cytotoxic T cells in vivo.
Conservation of viral miRNAs
The specificity of a miRNA can be altered by changing just one or two bases, especially in the seed region 19 , so the genomic sequences encoding viral miRNAs might therefore be subject to rapid evolutionary drift. But if the presence of a particular viral miRNA results in a significant increase in viral replication, then the gene encoding this miRNA might be expected to be conserved. Furthermore, if a viral miRNA targets a viral mRNA, co-evolution might be expected to occur. By contrast, if a viral miRNA targets a cellular mRNA, then the evolution of the viral miRNA gene might be expected to be restricted.
In fact, analysis of miRNAs encoded by different members of the herpes virus and polyoma virus families has so far uncovered little sequence conservation. One exception occurs in EBV and its simian relative rhesus lymphocryptovirus: 7 of the 16 miRNAs encoded by rhesus lympho cryptovirus are markedly similar to EBV miRNAs 2 . Because EBV and rhesus lymphocryptovirus are thought to have diverged ~13 million years ago, this suggests a strong evolutionary pressure for retaining the same miRNA sequences, especially as genomic sequences adjacent to the regions encoding the mature miRNAs (for example, those encoding the terminal loop of the pre-miRNA) were found to have diverged significantly 2 . By contrast, other related viruses (for example KSHV and rhesus rhadinovirus or Marek's disease virus types 1 and 2) show no miRNA sequence conservation 9, 12 , although the genomic location of the mi RNAs encoded by these viruses is conserved. Conservation of genomic lo cation, but lack of sequence similarity, is also observed for the simian polyoma virus SV40 and its human relatives the BK virus and JC virus, all of which express miRNAs that are antisense to, and degrade, viral T-antigen mRNAs 14, 15 . This finding might imply that the sole function of the miRNAs expressed by these viruses is to target these particular viral mRNAs 15 . However, viral miRNAs with no known viral mRNA targets also tend to be transcribed from the same genomic location, even when their nucleotide sequences have diverged 2, 9, 12 . So it might simply be easier for favourable sequence changes to be selected in genomic sequences that encode a pre-existing miRNA stem-loop structure than for a novel stem-loop structure to be generated de novo. It therefore remains possible that these diverse polyoma virus miRNAs also target cellular mRNAs for downregulation. Moreover, the fact that two viral mi RNAs have divergent sequences does not necessarily imply that they have different functions. Two distinct miRNAs, encoded by two dif ferent viruses, could, for example, target two distinct regions in a single mRNA 3ʹ UTR, or they could target two gene products that function at different steps in the same host metabolic pathway, resulting in a similar phenotype. Until the mRNA targets for viral miRNAs are better understood, and until there is some idea of their in vivo functions, the conservation (or lack of conservation) of viral miRNAs is not readily interpretable.
Outlook
Despite our still limited knowledge of viral miRNA functions, the large number of miRNAs that are encoded by diverse members of the herpesvirus family, and their high-level expression during latent infections, suggests that these small non-coding RNAs have a key role in regulating viral pathogenesis in vivo. In particular, it will be important to test the hypothesis that herpesvirus miRNAs that are produced during latency help to maintain the latent state 8, 20 , which could be examined by using viral mutants and/or antisense reagents. It certainly seems possible that antisense reagents specific for particular viral miRNAs could significantly attenuate herpesvirus-induced diseases in humans, if they could be delivered effectively to infected cells in vivo. 
